WeedMD Inc.

lockPrivate Group

WeedMD is a Health Canada Licensed Producer under the Access to Cannabis for Medical Purposes Regulations (ACMPR).

people11 Members       (0)

Corporate Profile
Group Admins:
  • Thumb 8020 monitor 200200 2
Request Membership


WeedMD Inc.

lockPrivateGroup

WeedMD is a Health Canada Licensed Producer under the Access to Cannabis for Medical Purposes Regulations (ACMPR)....

people11 Members       (0)

Thumb 8020 monitor 200200 2

8020 Admin

8 days ago

8020 Admin posted a press release WeedMD Subsidiary Starseed Medicinal Signs the International Association of Heat and Frost Insulators and Allied Workers Local 95 to its Medical Cannabis Program in WEEDMD INC.

Starseed is now the preferred medical cannabis supplier to the Insulators Local 95 Health & Welfare Trust Fund through their benefits program


TORONTO, Feb. 26, 2020 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce that its subsidiary Starseed Medicinal Inc. (“Starseed”) is now the preferred supplier of medical cannabis to the Insulators Local 95 Health & Welfare Trust Fund. The agreement provides union members and their dependents access to medical cannabis as an insured benefit with no co-pay or out-of-pocket costs.


“Starseed’s unique and proprietary program is rapidly becoming the platform of choice for benefits providers, insurers and their members looking to seamlessly add medical cannabis in a responsible way,” said Angelo Tsebelis, CEO of WeedMD. “We have rolled-out a streamlined process for introducing medical cannabis as part of an individual’s health and wellness journey by developing personalized treatment plans with healthcare experts, and by simplifying the reimbursement process. As a result, we are seeing broader acceptance to medical cannabis and we are pleased to welcome the Insulators Local 95 Health & Welfare Trust Fund’s members to Starseed’s full-service medical cannabis program.”


“We are proud to introduce Starseed’s progressive, full-service medical cannabis platform to our members and their employers who are looking to expand their health and wellness therapies with the safe access to medical cannabis,” said Jeffrey C. Baldwin, President - Benefit Plan Administrators (BPA) Limited, the administrator of the Insulators Local 95 Health & Welfare Trust Fund.  “Together, we are educating and removing the financial barriers as we legitimize cannabis as a medical and wellness therapy for our members.”


Starseed and WeedMD are focused on delivering premium medical cannabis products through a unique education and service model. Access WeedMD’s investor presentation here.


About WeedMD Inc.


WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer of cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, Ontario. WeedMD also operates CX Industries Inc., a wholly-owned subsidiary of WeedMD Inc., from the Company’s fully-licensed 26,000 sq. ft. Aylmer, Ontario production facility which specializes in cannabis extraction and processing. With the recent acquisition of Starseed Medicinal Inc., a medical-centric licensed holder with operations in Bowmanville, Ontario, WeedMD has expanded its multi-channeled distribution strategy. Starseed’s industry-first, exclusive partnerships with union groups, employers and benefit providers in Canada, complements WeedMD’s direct sales to medical patients. The Company maintains strategic relationships across the seniors’ market and supply agreements with Shoppers Drug Mart as well as six provincial distribution agencies where its adult-use brands Color Cannabis and Saturday are sold.


Follow WeedMD, Color Cannabis & Starseed: 


Facebook: https://www.facebook.com/weedmd/
LinkedIn: https://ca.linkedin.com/company/weedmd
Twitter: https://twitter.com/WeedMD
Instagram: https://www.instagram.com/weedmd/


Instagram: https://www.instagram.com/callitcolor/
&
Instagram: https://www.instagram.com/starseedca/


For further information, please contact:


For Investor Enquiries:
Stephen Ng
Chief Strategy Officer
Email: investor@weedmd.com


For Media Enquiries:
Marianella delaBarrera
VP, Communications & Corporate Affairs
Tel: 416-897-6644
Email: marianella@weedmd.com


Forward Looking Information


This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation which are based upon WeedMD's current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as "expect", "likely", "may", "will", "should", "intend", "anticipate", "potential", "proposed", "estimate" and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions "may", "would" or "will" happen, or by discussions of strategy.


The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Forward-looking information in this news release include, but are not limited to, statements with respect to internal expectations, expectations with respect to actual production volumes, expectations for future growing capacity and the completion of any capital project or expansions. Forward-looking information necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of WeedMD to implement its business strategies; competition; crop failure; and other risks.


Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, WeedMD does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for WeedMD to predict all such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in WeedMD's Annual Information Form dated June 21, 2019 (the "AIF") and other disclosure documents of WeedMD filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in the AIF and other disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.


NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE 



Primary Logo


!
Thumb 8020 monitor 200200 2

8020 Admin

10 days ago

8020 Admin posted a press release WeedMD Subsidiary Starseed Medicinal Signs the International Union of Painters and Allied Trades to Medical Cannabis Program in WEEDMD INC.

Starseed is now the preferred medical cannabis supplier to IUPAT Province of Ontario Health & Welfare Trust Fund through their benefits program


TORONTO, Feb. 24, 2020 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce that its subsidiary Starseed Medicinal Inc. (“Starseed”) is now the preferred supplier of medical cannabis to the IUPAT Province of Ontario Health & Welfare Trust Fund’s participants. The agreement provides approximately 7,000 IUPAT members and their dependents with medical cannabis as an insured benefit, with no co-pay or out-of-pocket costs.


“We are honoured to welcome the IUPAT members to Starseed’s full-service medical platform which is now being sourced from WeedMD’s medical-grade cannabis production platform,” said Angelo Tsebelis, CEO of WeedMD. “Our end-to-end service model eliminates the many barriers associated with traditional ways of accessing cannabis and is transforming how Canadians access medical cannabis. We are pleased to work with progressive partners to continue to legitimize cannabis as an effective treatment option.” 


“Providing our members with safe access to a broad and diverse range of medical cannabis therapies to suit their individual health and wellness needs is a positive step forward in sourcing alternatives to traditional pharma therapies,” said Jeffrey C. Baldwin, President – Benefit Plan Administrators (BPA) Limited, the administrator of the International Union of Painters and Allied Trades. “As cannabis industry leaders, Starseed and WeedMD are trusted sources of medical cannabis and we’re proud to partner with them to facilitate safe and affordable access for our members.”


Starseed and WeedMD are focused on delivering premium medical cannabis products through a unique education and service model. Access WeedMD’s investor presentation here.


Investor Relations Service Agreement


WeedMD also announced today that it has engaged KCSA Strategic Communications (“KCSA”), to provide investor relations services effective as of February 24, 2020 (the “Service Agreement”).  Pursuant to the Service Agreement, KCSA will provide comprehensive investor relations services for an initial term of six months and unless terminated by either party, will thereafter be automatically renewed on a month-to-month basis.  Pursuant to the Service Agreement, WeedMD will pay KCSA a monthly base fee of US$8,000, plus reasonable out-of-pocket expenses.  KCSA does not currently own any shares of WeedMD nor does it have any other direct or indirect interest in WeedMD. 


About WeedMD Inc.


WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer of cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, Ontario. WeedMD also operates CX Industries Inc., a wholly-owned subsidiary of WeedMD Inc., from the Company’s fully-licensed 26,000 sq. ft. Aylmer, Ontario production facility which specializes in cannabis extraction and processing. With the recent acquisition of Starseed Medicinal Inc., a medical-centric licensed holder with operations in Bowmanville, Ontario, WeedMD has expanded its multi-channeled distribution strategy. Starseed’s industry-first, exclusive partnerships with union groups, employers and benefit providers in Canada, complements WeedMD’s direct sales to medical patients. The Company maintains strategic relationships across the seniors’ market and supply agreements with Shoppers Drug Mart as well as six provincial distribution agencies where its adult-use brands Color Cannabis and Saturday are sold.


Follow WeedMD, Color Cannabis & Starseed: 


Facebook: https://www.facebook.com/weedmd/
LinkedIn: https://ca.linkedin.com/company/weedmd
Twitter: https://twitter.com/WeedMD
Instagram: https://www.instagram.com/weedmd/
Instagram: https://www.instagram.com/callitcolor/|
&
Instagram: https://www.instagram.com/starseedca/


For further information, please contact:


For Investor Enquiries:
Stephen Ng
Chief Strategy Officer
Email: investor@weedmd.com


For Media Enquiries:
Marianella delaBarrera
VP, Communications & Corporate Affairs
Tel: 416-897-6644
Email: marianella@weedmd.com


Forward Looking Information


This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation which are based upon WeedMD's current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as "expect", "likely", "may", "will", "should", "intend", "anticipate", "potential", "proposed", "estimate" and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions "may", "would" or "will" happen, or by discussions of strategy.


The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Forward-looking information in this news release include, but are not limited to, statements with respect to internal expectations, expectations with respect to actual production volumes, expectations for future growing capacity and the completion of any capital project or expansions. Forward-looking information necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of WeedMD to implement its business strategies; competition; crop failure; and other risks.


Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, WeedMD does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for WeedMD to predict all such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in WeedMD's Annual Information Form dated June 21, 2019 (the "AIF") and other disclosure documents of WeedMD filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in the AIF and other disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.


NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE


 Primary Logo


!
Thumb 8020 monitor 200200 2

8020 Admin

21 days ago

8020 Admin posted a press release WeedMD Subsidiary Starseed Medicinal Secures Cannabis Research Licence from Health Canada in WEEDMD INC.

New licence allows for ongoing product development and the evaluation of cannabis concentrates in portable vaporizer devices for optimal formulations


TORONTO, Feb. 13, 2020 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce that its subsidiary Starseed Medicinal Inc. (“Starseed”) has been awarded a cannabis research licence by Heath Canada (“Research Licence”). This allows for the testing of cannabis concentrates pertaining specifically to vaporization (vape) products in development testing at its Bowmanville, Ontario facility.


“With the evolution of next generation cannabis products such as extracts for vaporization, we want to ensure we drive important data collection forward on behalf of our patients and consumers,” said Angelo Tsebelis, CEO of WeedMD. “We are diligently assessing new cannabis products - in this case, specific to vapes - to determine optimum formulations that will result in the best performance and delivery of medical cannabis, as well as consumer acceptability.”


The Research Licence gives way to research activities and protocols that involve direct handling and storage of cannabis. It also allows for the administration and distribution of cannabis to focus group subjects for assessment of taste, sight, smell and/or touch. The research program is also expected to assess the effect of storage conditions on vaporization device cartridges to ensure product stability in various use conditions over time.


WeedMD also announced that as part of the transaction with Starseed Holdings Inc., the Company granted the following options: 5,674,875 options with an exercise price of $0.98 per share expiring November 3, 2022; and, 900,311 WeedMD options with an exercise price of $3.26 per share expiring November 1, 2023.


Access WeedMD’s investor presentation here.


About WeedMD Inc.


WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer of cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, Ontario. WeedMD also operates CX Industries Inc., a wholly-owned subsidiary of WeedMD Inc., from the Company’s fully-licensed 26,000 sq. ft. Aylmer, Ontario production facility which specializes in cannabis extraction and processing. With the recent acquisition of Starseed Medicinal Inc., a medical-centric licensed holder with operations in Bowmanville, Ontario, WeedMD has expanded its multi-channeled distribution strategy. Starseed’s industry-first, exclusive partnership with LiUNA, the largest construction union in Canada, along with other employers and union groups complements WeedMD’s direct sales to medical patients. The Company maintains strategic relationships across the seniors’ market and supply agreements with Shoppers Drug Mart as well as six provincial distribution agencies where its adult-use brands Color Cannabis and Saturday are sold.


Follow WeedMD, Color Cannabis & Starseed: 


Facebook: https://www.facebook.com/weedmd/
LinkedIn: https://ca.linkedin.com/company/weedmd
Twitter: https://twitter.com/WeedMD
Instagram: https://www.instagram.com/weedmd/


Instagram: https://www.instagram.com/callitcolor/
&
Instagram: https://www.instagram.com/starseedca/


For further information, please contact:


For Investor Enquiries:
Stephen Ng
Chief Strategy Officer
Email: investor@weedmd.com


For Media Enquiries:
Marianella delaBarrera
VP, Communications & Corporate Affairs
Tel: 416-897-6644
Email: marianella@weedmd.com


To learn more, visit us at www.weedmd.com


Forward Looking Information


This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation which are based upon WeedMD's current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as "expect", "likely", "may", "will", "should", "intend", "anticipate", "potential", "proposed", "estimate" and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions "may", "would" or "will" happen, or by discussions of strategy.


The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Forward-looking information in this news release include, but are not limited to, statements with respect to internal expectations, expectations with respect to actual production volumes, expectations for future growing capacity and the completion of any capital project or expansions. Forward-looking information necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of WeedMD to implement its business strategies; competition; crop failure; and other risks.


Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, WeedMD does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for WeedMD to predict all such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in WeedMD's Annual Information Form dated June 21, 2019 (the "AIF") and other disclosure documents of WeedMD filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in the AIF and other disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.


NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE


Primary Logo


!
Thumb 8020 monitor 200200 2

8020 Admin

24 days ago

8020 Admin posted a press release WeedMD Subsidiary Starseed Medicinal Signs Innovative Benefits Provider myHSA to Medical Cannabis Program in WEEDMD INC.

Starseed and WeedMD become preferred medical cannabis suppliers to over 51,000 myHSA clients across Canada


TORONTO, Feb. 10, 2020 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce that its subsidiary Starseed Medicinal Inc. (“Starseed”) is now the preferred supplier of medical cannabis to over 51,000 eligible myHSA participants across Canada. Selling its platform through a network of over 2,600 advisors, working with over 8,500 employers, myHSA is widely recognized for its unique digital wellness and reimbursement platform that provides a flexible, interactive benefits menu.


“More companies are recognizing that wellness programs are an effective way to engage employees in healthier living and we’re pleased to partner with innovative benefits provider myHSA as it looks to expand access to quality cannabis products to its 51,000 members,” said Angelo Tsebelis, CEO of WeedMD. “With the onset of flexible digital solutions, myHSA’s eligible participants get direct access to our patient portals and full-service medical cannabis program as well as easy digital access to claim reimbursement and adjudication.”

“At myHSA, we strongly believe that employees need to be in control of their wellness journey and with the advent of alternative therapies, we wanted to partner with a trusted source of medical cannabis products to ensure our participants have access to top quality products from Starseed and WeedMD,” said Tim Kane, CEO of myHSA. “We’ve created a platform that empowers participants to choose how they would like to spend their wellness dollars as a way to motivate and inspire a more holistic approach to benefits coverage.”


Launched in 2013, myHSA has grown and is the main spending account provider to over 51,000 employees across Canada. The myHSA system is a software that is used by advisors to implement different forms of health spending accounts, insurance products, and other unique employee benefits. More about myHSA here.


Access WeedMD’s investor presentation here.


About WeedMD Inc.


WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer of cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, Ontario. WeedMD also operates CX Industries Inc., a wholly-owned subsidiary of WeedMD Inc., from the Company’s fully-licensed 26,000 sq. ft. Aylmer, Ontario production facility which specializes in cannabis extraction and processing. With the recent acquisition of Starseed Medicinal Inc., a medical-centric licensed holder with operations in Bowmanville, Ontario, WeedMD has expanded its multi-channeled distribution strategy. Starseed’s industry-first, exclusive partnership with LiUNA, the largest construction union in Canada, along with other employers and union groups complements WeedMD’s direct sales to medical patients. The Company maintains strategic relationships across the seniors’ market and supply agreements with Shoppers Drug Mart as well as six provincial distribution agencies where its adult-use brands Color Cannabis and Saturday are sold.


Follow WeedMD, Color Cannabis & Starseed: 


Facebook: https://www.facebook.com/weedmd/
LinkedIn: https://ca.linkedin.com/company/weedmd
Twitter: https://twitter.com/WeedMD
Instagram: https://www.instagram.com/weedmd/


Instagram: https://www.instagram.com/callitcolor/
&
Instagram: https://www.instagram.com/starseedca/


For further information, please contact:


For Investor Enquiries:
Stephen Ng
Chief Strategy Officer
Email: investor@weedmd.com


For Media Enquiries:
Marianella delaBarrera
VP, Communications & Corporate Affairs
Tel: 416-897-6644
Email: marianella@weedmd.com


To learn more, visit us at www.weedmd.com


Forward Looking Information


This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation which are based upon WeedMD's current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as "expect", "likely", "may", "will", "should", "intend", "anticipate", "potential", "proposed", "estimate" and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions "may", "would" or "will" happen, or by discussions of strategy.


The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Forward-looking information in this news release include, but are not limited to, statements with respect to internal expectations, expectations with respect to actual production volumes, expectations for future growing capacity and the completion of any capital project or expansions. Forward-looking information necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of WeedMD to implement its business strategies; competition; crop failure; and other risks.


Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, WeedMD does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for WeedMD to predict all such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in WeedMD's Annual Information Form dated June 21, 2019 (the "AIF") and other disclosure documents of WeedMD filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in the AIF and other disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.


NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE


Primary Logo


!
Thumb 8020 monitor 200200 2

8020 Admin

29 days ago

8020 Admin posted a press release WeedMD Wins Award for London's Best Places to Work 2020 in WEEDMD INC.


TORONTO, Feb. 05, 2020 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce that it has been named winner in the large-size business category of London’s Best Places to Work 2020 awards program, presented by London Inc. Magazine.


“These awards recognize employers in the southwestern Ontario area that have gone above and beyond to create outstanding workplace environments,” said Gord Delamont, founder and editor of London Inc. Magazine. “In recognition of this achievement, we are pleased to showcase WeedMD in the Best Places to Work 2020 feature cover story and we congratulate them for promoting a positive and trusting workspace that motivates staff to produce quality products to drive success.”


“This award is truly meaningful for the WeedMD team because our own employees nominated and championed the vote. Our people strategy is built on a strong sense of community that fosters pride, passion and collaboration at every level,” said Josephine DesLauriers, SVP of People, WeedMD. “We are thrilled to be selected as one of London’s Best Places to Work. Our highly engaged employee base remains the backbone of our world-class cannabis cultivation platform that now spans three production sites and two corporate offices, including our newly-minted London office.”


The annual awards recognize top workplaces in the London, Ontario region based on a comprehensive workplace survey conducted by Ahria Consulting, a human resources management consulting firm. Winners are chosen through a survey evaluation of multiple employee engagement metrics, including employee commitment, effort, and interest. WeedMD is a winner in the large-size business category.


WeedMD is currently nominated as a finalist for the London Chamber of Commerce Business Achievement Awards – in the Best Agricultural Business Category. The winners will be announced on March 25, 2020 in London. Last year, WeedMD was named the top licensed producer in Indeed’s Hottest Places to Work according to Indeed job seekers.


Access WeedMD’s investor presentation here.


About WeedMD Inc.


WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer of cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, Ontario. WeedMD also operates CX Industries Inc., a wholly-owned subsidiary of WeedMD Inc., from the Company’s fully-licensed 26,000 sq. ft. Aylmer, Ontario production facility which specializes in cannabis extraction and processing. With the recent acquisition of Starseed Medicinal Inc., a medical-centric licensed holder with operations in Bowmanville, Ontario, WeedMD has expanded its multi-channeled distribution strategy. Starseed’s industry-first, exclusive partnership with LiUNA, the largest construction union in Canada, along with other employers and union groups complements WeedMD’s direct sales to medical patients. The Company maintains strategic relationships across the seniors’ market and supply agreements with Shoppers Drug Mart as well as six provincial distribution agencies where its adult-use brands Color Cannabis and Saturday are sold.


Follow WeedMD, Color Cannabis & Starseed: 


Facebook: https://www.facebook.com/weedmd/
LinkedIn: https://www.linkedin.com/company/weedmd/?originalSubdomain=fr
Twitter: https://twitter.com/WeedMD
Instagram: https://www.instagram.com/weedmd/
Instagram: https://www.instagram.com/callitcolor/
Instagram: https://www.instagram.com/starseedca/


For further information, please contact:


For Investor Enquiries:
Stephen Ng
Chief Strategy Officer
Email: investor@weedmd.com


For Media Enquiries:
Marianella delaBarrera
VP, Communications & Corporate Affairs
Tel: 416-897-6644
Email: marianella@weedmd.com


To learn more, visit us at www.weedmd.com

Forward Looking Information


This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation which are based upon WeedMD's current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as "expect", "likely", "may", "will", "should", "intend", "anticipate", "potential", "proposed", "estimate" and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions "may", "would" or "will" happen, or by discussions of strategy.


The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Forward-looking information in this news release include, but are not limited to, statements with respect to internal expectations, expectations with respect to actual production volumes, expectations for future growing capacity and the completion of any capital project or expansions. Forward-looking information necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of WeedMD to implement its business strategies; competition; crop failure; and other risks.


Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, WeedMD does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for WeedMD to predict all such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in WeedMD's Annual Information Form dated June 21, 2019 (the "AIF") and other disclosure documents of WeedMD filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in the AIF and other disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.


NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE 



Primary Logo


!
Thumb 8020 monitor 200200 2

8020 Admin

2 months ago

8020 Admin posted a press release WeedMD to Hold Special Meeting of Shareholders on February 4th, 2020 at 10:00 a.m. to Finalize $25M Strategic Equity Investment in WEEDMD INC.


TORONTO, Jan. 20, 2020 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to confirm that a special meeting (“Meeting”) of shareholders (the “Shareholders”) of WeedMD will take place as scheduled on February, 4, 2020 at 10:00 a.m. (EST) at Fogler, Rubinoff LLP, located at TD Centre North Tower, Suite 3000, 77 King Street West, Toronto, Ontario.


The Meeting is being held in connection with the private placement of subscription receipts (the “Subscription Receipts”) with the LiUNA Pension Fund of Central and Eastern Canada (“LPF”) for gross proceeds of $25 million, which was completed as part of WeedMD's acquisition of Starseed Holdings Inc. ("Starseed").  Upon WeedMD receiving the requisite shareholder approvals at the Meeting, the Subscription Receipts will automatically convert into WeedMD common shares. Further details about the financing are contained in the Meeting information circular (the "Circular") which is available for download on WeedMD’s SEDAR profile here.


Shareholders as of the record date of December 30, 2019 will have the right to vote by proxy or in person at the Meeting. All Shareholder votes are important and each is encouraged to take the time to read the Circular and vote prior to the voting deadline of January 31, at 10:00 a.m. (EST).


In connection with the closing of the Starseed acquisition, WeedMD will be issuing 538,756 common shares to Stoic Advisory Inc. as consideration for financial advisory services provided to WeedMD.  In addition, upon completion of the $25 million equity investment, an additional 153,637 common shares will be issued to Stoic.


Access WeedMD’s investor presentation here and AGM corporate video highlights here.


About WeedMD Inc.


WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer of cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, Ontario. WeedMD also operates CX Industries Inc., a wholly-owned subsidiary of WeedMD Inc., from the Company’s fully-licensed 26,000 sq. ft. Aylmer, Ontario production facility which specializes in cannabis extraction and processing. With the recent acquisition of Starseed Medicinal Inc., a medical-centric licensed holder with operations in Bowmanville, Ontario, WeedMD has expanded its multi-channeled distribution strategy. Starseed’s industry-first, exclusive partnership with LiUNA, the largest construction union in Canada, along with other employers and union groups complements WeedMD’s direct sales to medical patients. The Company maintains strategic relationships across the seniors’ market and supply agreements with Shoppers Drug Mart as well as six provincial distribution agencies where its adult-use brands Color Cannabis and Saturday are sold.


Follow WeedMD, Color Cannabis & Starseed:                                                                       


Facebook: https://www.facebook.com/weedmd/
LinkedIn: https://ca.linkedin.com/company/weedmd 
Twitter: https://twitter.com/WeedMD
Instagram: https://www.instagram.com/weedmd/


Instagram: https://www.instagram.com/callitcolor/


&


Instagram: https://www.instagram.com/starseedca/


For further information, please contact:


For Investor Enquiries:
Stephen Ng
Chief Strategy Officer
Email: investor@weedmd.com


For Media Enquiries:
Marianella delaBarrera
VP, Communications & Corporate Affairs
Tel: 416-897-6644
Email: marianella@weedmd.com


To learn more, visit us at www.weedmd.com


Forward Looking Information


This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation which are based upon WeedMD's current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as "expect", "likely", "may", "will", "should", "intend", "anticipate", "potential", "proposed", "estimate" and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions "may", "would" or "will" happen, or by discussions of strategy.


The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Forward-looking information in this news release include, but are not limited to, statements with respect to internal expectations, expectations with respect to actual production volumes, expectations for future growing capacity and the completion of any capital project or expansions. Forward-looking information necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of WeedMD to implement its business strategies; competition; crop failure; and other risks.


Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, WeedMD does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for WeedMD to predict all such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in WeedMD's Annual Information Form dated June 21, 2019 (the "AIF") and other disclosure documents of WeedMD filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in the AIF and other disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.


NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE


Primary Logo


!
Thumb 8020 monitor 200200 2

8020 Admin

2 months ago

8020 Admin posted a press release WeedMD Subsidiary Starseed Medicinal Signs LiUNA's London, Ontario Local to Medical Cannabis Program in WEEDMD INC.

Starseed is now the preferred medical cannabis supplier to five LiUNA Locals including London Local 1059’s 4,000 members through their health benefit plan


TORONTO, Jan. 16, 2020 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce that its newly-acquired subsidiary Starseed Medicinal Inc. (“Starseed”) has launched its full-service medical cannabis program as the preferred supplier of medical cannabis to  Labourers’ International Union of North America (LiUNA) Local 1059, headquartered in London, Ontario. The agreement provides approximately 4,000 members and their dependents with medical cannabis as a reimbursed benefit with no co-pay or out-of-pocket costs.


LiUNA is the largest construction union in Canada and LiUNA Local 1059 becomes the fifth LiUNA local to be onboarded onto Starseed’s medical cannabis program following launches in Toronto, Hamilton-Niagara and Windsor. Additional LiUNA locals are expected to join in 2020 along with other new insurance payor groups.


“Starseed’s full service medical platform – coupled with WeedMD’s medical-grade cannabis products - is revolutionizing the way Canadians access medical cannabis and we welcome LiUNA Local 1059 members to our program,” said Angelo Tsebelis, President of Starseed. “WeedMD and Starseed are improving fair and safe access to medical cannabis with an end-to-end service model that eliminates many of the practical and financial barriers associated with traditional ways of accessing cannabis as a medicine.” 


“It’s important to the Local 1059 Benefit Trustees that our 4,000 members have access to a broad and diverse range of medical therapies to suit their individual healthcare needs. Having the opportunity to collaborate with some of the most trusted names in medical cannabis was a key driver for entering into this agreement with Starseed,” said Brandon MacKinnon, Business Manager of LiUNA Local 1059. “Additionally, WeedMD has a strong reputation in our city and we’re looking forward to working with this local licensed producer to educate and facilitate medical cannabis access for our members.”


“We’ve kicked off the new year as a freshly integrated company and we’re thrilled at the many strategic business opportunities and partnerships that Starseed is bringing forward – perfectly aligned with our best-in-class cultivation program,” said Keith Merker, CEO of WeedMD. “As long-time supporters of our hometown London community coupled with our strong commitment to medical cannabis, we welcome LiUNA Local 1059 and look forward to the continued engagement with our local patient base.”


About WeedMD Inc.


WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer of cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, Ontario. WeedMD also operates CX Industries Inc., a wholly-owned subsidiary of WeedMD Inc., from the Company’s fully-licensed 26,000 sq. ft. Aylmer, Ontario production facility which specializes in cannabis extraction and processing. With the recent acquisition of Starseed Medicinal Inc., a medical-centric licensed holder with operations in Bowmanville, Ontario, WeedMD has expanded its multi-channeled distribution strategy. Starseed’s industry-first, exclusive partnership with LiUNA, the largest construction union in Canada, along with other employers and union groups complements WeedMD’s direct sales to medical patients. The Company maintains strategic relationships across the seniors’ market and supply agreements with Shoppers Drug Mart as well as six provincial distribution agencies where its adult-use brands Color Cannabis and Saturday are sold.


Follow WeedMD, Color Cannabis & Starseed: 


Facebook: https://www.facebook.com/weedmd/
LinkedIn: https://www.linkedin.com/company/weedmd/?originalSubdomain=fr
Twitter: https://twitter.com/WeedMD
Instagram: https://www.instagram.com/weedmd/


Instagram: https://www.instagram.com/callitcolor/


 


&


Instagram: https://www.instagram.com/starseedca/


For further information, please contact:


For WeedMD Investor Enquiries:
Stephen Ng
Chief Strategy Officer
Email: investor@weedmd.com


For WeedMD Media Enquiries:
Marianella delaBarrera
VP, Communications & Corporate Affairs
Tel: 416-897-6644
Email: marianella@weedmd.com


For LiUNA Media Enquiries:
Victoria Mancinelli
Director of Communications, Public Relations and Marketing
Tel: 1-289-681-1703
Email: vmancinelli@liunaopdc.org


To learn more, visit us at www.weedmd.com


Forward Looking Information


This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation which are based upon WeedMD's current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as "expect", "likely", "may", "will", "should", "intend", "anticipate", "potential", "proposed", "estimate" and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions "may", "would" or "will" happen, or by discussions of strategy.


The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Forward-looking information in this news release include, but are not limited to, statements with respect to internal expectations, expectations with respect to actual production volumes, expectations for future growing capacity and the completion of any capital project or expansions. Forward-looking information necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of WeedMD to implement its business strategies; competition; crop failure; and other risks.


Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, WeedMD does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for WeedMD to predict all such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in WeedMD's Annual Information Form dated June 21, 2019 (the "AIF") and other disclosure documents of WeedMD filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in the AIF and other disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.


NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE


Primary Logo


!
Thumb 8020 monitor 200200 2

8020 Admin

2 months ago

8020 Admin posted a press release WeedMD Closes Acquisition of Starseed Holdings Inc. and $25 Million Subscription Receipt Financing in WEEDMD INC.

Company enhances management team & board of directors, announces new chair


TORONTO, Dec. 23, 2019 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, and Starseed Holdings Inc. (“Starseed”), a medically-focused, federally-licensed cannabis company, are pleased to announce the closing of the previously announced acquisition of Starseed Holdings by WeedMD (the “Acquisition”).


Concurrent with the closing, WeedMD also completed the previously announced private placement of subscription receipts (the “Subscription Receipts”) with the LiUNA Pension Fund of Central and Eastern Canada (“LPF”), for aggregate gross proceeds of $25 million. The issue price of each Subscription Receipt is $1.0832, and each Subscription Receipt shall be automatically exchangeable into one WeedMD common share upon its shareholders approving certain matters associated with the financing at a meeting scheduled for February 4, 2020.


“We officially welcome the Starseed team to the WeedMD family which together will kick-off 2020 as a very compelling, vertically-integrated cannabis company that will execute across the entire value chain,” said Keith Merker, CEO of WeedMD. “Starseed’s unique medical distribution platform complements WeedMD’s high-quality cultivation and processing platform. This partnership, along with the $25 million strategic equity investment by LPF, positions WeedMD and its shareholders with a fortified balance sheet and one of the most captive medical cannabis businesses in the country as we enter the new year.”


Management Team


Following today’s closing, Starseed’s management team, which brings extensive medical, operating, and financial expertise, in addition to strong industry and client relationships, integrates into WeedMD’s senior leadership team as follows:



  • Keith Merker, CEO (maintains role)

  • Angelo Tsebelis, formerly President of Starseed, assumes the role of President of WeedMD

  • Nichola Thompson, CFO (maintains role)

  • Stephen Ng, formerly CFO of Starseed, is appointed to Chief Strategy Officer of WeedMD

  • Dr. Peter Blecher, formerly Chief Medical Officer of Starseed, assumes the role of Chief Medical Officer of WeedMD


Additional information about WeedMD’s current management team can be found here.


Board Directors


In addition to the Starseed leadership appointments, WeedMD’s board of directors is now comprised of four representatives from WeedMD and three representatives from Starseed.


WeedMD is pleased to announce that seasoned industry leader George Scorsis is appointed as Executive Chair of its board of directors. For the last six months, Mr. Scorsis has served as executive advisor to the WeedMD board and leadership team and is widely recognized in the cannabis and beverage industries for building, leading and managing high-performing management teams.


WeedMD extends its gratitude to Michael Kraft who has served as Chair of its board of directors since the Company’s inception. As one of WeedMD’s co-founders, Mr. Kraft has been integral to its growth and success over the years and we are pleased he has accepted the role of strategic advisor to the board which includes the existing WeedMD directors:



  • Keith Merker, currently CEO of WeedMD

  • Gail Paech, formerly Associate Deputy Minister, Ministry of Health, Ontario

  • Michael Pesner, previously on the board of SAQ (Société des alcools du Québec),  and KPMG executive leader


WeedMD is pleased to welcome three new board directors from Starseed:  



  • Angelo Tsebelis, currently President of WeedMD

  • G. Edmund King, former CEO and Chairman of CIBC Wood Gundy

  • Dr. Hugh Scully, previously President of both the Ontario & Canadian Medical Associations


Additional information about WeedMD’s current board of directors can be found here.


The Company would also like to thank Rick Moscone and Kevin McGovern who have elected to step down following three years and one year of service, respectively.


Pursuant to the Acquisition, WeedMD acquired 100% of the issued and outstanding common shares of Starseed and in exchange Starseed shareholders received a total of approximately 71.8 million common shares of WeedMD. Certain shareholders of Starseed, holding approximately 49 million common shares of WeedMD, have agreed to an 18-month lock-up and leak out agreement.


About WeedMD Inc.


WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer of cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, Ontario. WeedMD also operates CX Industries Inc., a wholly-owned subsidiary of WeedMD Inc., from the Company’s fully-licensed 26,000 sq. ft. Aylmer, Ontario production facility which specializes in cannabis extraction and processing. With the recent acquisition of Starseed Medicinal Inc., a medical-centric licensed holder with operations in Bowmanville, Ontario, WeedMD has expanded its multi-channeled distribution strategy. Starseed’s industry-first, exclusive partnership with LiUNA, the largest construction union in Canada, along with other employers and union groups complements WeedMD’s direct sales to medical patients. The Company maintains strategic relationships across the seniors’ market and supply agreements with Shoppers Drug Mart as well as six provincial distribution agencies where its adult-use brands Color Cannabis and Saturday are sold.


Follow WeedMD, Color Cannabis & Starseed: 


Facebook
LinkedIn
Twitter
Instagram Weed MD
Instagram Color Cannabis
Instagram Starseed


For further information, please contact:


For Investor Inquiries:
James Williams
Director, Capital Markets
Email: investor@weedmd.com


For Media Enquiries:
Marianella delaBarrera
VP, Communications & Corporate Affairs
Tel: 416-897-6644
Email: marianella@weedmd.com


To learn more, visit us at www.weedmd.com


Forward Looking Information:


This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation which are based upon WeedMD’s current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as “expect”, “likely”, “may”, “will”, “should”, “intend”, “anticipate”, “potential”, “proposed”, “estimate” and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions “may”, “would” or “will” happen, or by discussions of strategy.


The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Forward-looking information in this news release include, but are not limited to, statements with respect to internal expectations, expectations with respect to actual production volumes, expectations for future growing capacity and the completion of any capital project or expansions. Forward-looking information necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of WeedMD to implement its business strategies; competition; crop failure; and other risks.


Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, WeedMD does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for WeedMD to predict all such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in WeedMD’s Annual Information Form dated June 21, 2019 (the “AIF”) and other disclosure documents of WeedMD filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in the AIF and other disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.


NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE


Primary Logo


!
Thumb 8020 monitor 200200 2

8020 Admin

3 months ago

8020 Admin posted a press release WeedMD Posts Open Letter to Shareholders in WEEDMD INC.


TORONTO, Dec. 02, 2019 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, announced today that it has posted an open letter to its shareholders to provide additional background information about its recent 27-acre outdoor harvest yields, the Starseed Holdings Inc. (“Starseed”) acquisition, and the $25 million strategic investment from the Labourers’ Pension Fund of Central and Eastern Canada (known as “LPF”) (the “Transaction”). The Shareholder Letter was cascaded earlier today and can be found on WeedMD’s website here.


Access the WeedMD and Starseed Transaction deck here.


About WeedMD Inc.


WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer of cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, Ontario. WeedMD also operates CX Industries Inc., a wholly-owned subsidiary of WeedMD Inc. CX Industries operates out of the Company’s fully-licensed 26,000 sq. ft. Aylmer, Ontario production facility which specializes in cannabis extraction and processing. WeedMD has a multi-channeled distribution strategy that includes selling directly to medical patients, strategic relationships across the seniors’ market and supply agreements with Shoppers Drug Mart as well as six provincial distribution agencies where WeedMD’s adult-use brand Color Cannabis is sold.

Follow WeedMD & Color Cannabis: 


Facebook: https://www.facebook.com/weedmd/
LinkedIn: https://www.linkedin.com/company/weedmd/?originalSubdomain=fr
Twitter: https://twitter.com/WeedMD
Instagram: https://www.instagram.com/weedmd/
&
https://www.instagram.com/callitcolor/   


For further information, please contact WeedMD Inc.:


For Investor Inquiries:
James Williams
Director, Capital Markets
Email: investor@weedmd.com


For Media Inquiries:


Marianella delaBarrera
VP, Communications & Corporate Affairs
Tel: 416-897-6644
Email: marianella@weedmd.com
To learn more, visit us at www.weedmd.com


Forward Looking Information


This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation which are based upon WeedMD's current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as "expect", "likely", "may", "will", "should", "intend", "anticipate", "potential", "proposed", "estimate" and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions "may", "would" or "will" happen, or by discussions of strategy.


The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Forward-looking information in this news release include, but are not limited to, statements with respect to internal expectations, expectations with respect to actual production volumes, expectations for future growing capacity and the completion of any capital project or expansions. Forward-looking information necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of WeedMD to implement its business strategies; competition; crop failure; and other risks.


Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, WeedMD does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for WeedMD to predict all such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in WeedMD's Annual Information Form dated June 21, 2019 (the "AIF") and other disclosure documents of WeedMD filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in the AIF and other disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.


NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE


Primary Logo


!

WeedMD Inc.

lockPrivate Group

WeedMD is a Health Canada Licensed Producer under the Access to Cannabis for Medical Purposes Regulations (ACMPR).

people11 Members       (0)

Corporate Profile
Group Admins:
  • Thumb 8020 monitor 200200 2
Request Membership


WeedMD Inc.

lockPrivateGroup

WeedMD is a Health Canada Licensed Producer under the Access to Cannabis for Medical Purposes Regulations (ACMPR)....

people11 Members       (0)

Thumb 8020 monitor 200200 2

8020 Admin

8 days ago

8020 Admin posted a press release WeedMD Subsidiary Starseed Medicinal Signs the International Association of Heat and Frost Insulators and Allied Workers Local 95 to its Medical Cannabis Program in WEEDMD INC.

Starseed is now the preferred medical cannabis supplier to the Insulators Local 95 Health & Welfare Trust Fund through their benefits program


TORONTO, Feb. 26, 2020 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce that its subsidiary Starseed Medicinal Inc. (“Starseed”) is now the preferred supplier of medical cannabis to the Insulators Local 95 Health & Welfare Trust Fund. The agreement provides union members and their dependents access to medical cannabis as an insured benefit with no co-pay or out-of-pocket costs.


“Starseed’s unique and proprietary program is rapidly becoming the platform of choice for benefits providers, insurers and their members looking to seamlessly add medical cannabis in a responsible way,” said Angelo Tsebelis, CEO of WeedMD. “We have rolled-out a streamlined process for introducing medical cannabis as part of an individual’s health and wellness journey by developing personalized treatment plans with healthcare experts, and by simplifying the reimbursement process. As a result, we are seeing broader acceptance to medical cannabis and we are pleased to welcome the Insulators Local 95 Health & Welfare Trust Fund’s members to Starseed’s full-service medical cannabis program.”


“We are proud to introduce Starseed’s progressive, full-service medical cannabis platform to our members and their employers who are looking to expand their health and wellness therapies with the safe access to medical cannabis,” said Jeffrey C. Baldwin, President - Benefit Plan Administrators (BPA) Limited, the administrator of the Insulators Local 95 Health & Welfare Trust Fund.  “Together, we are educating and removing the financial barriers as we legitimize cannabis as a medical and wellness therapy for our members.”


Starseed and WeedMD are focused on delivering premium medical cannabis products through a unique education and service model. Access WeedMD’s investor presentation here.


About WeedMD Inc.


WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer of cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, Ontario. WeedMD also operates CX Industries Inc., a wholly-owned subsidiary of WeedMD Inc., from the Company’s fully-licensed 26,000 sq. ft. Aylmer, Ontario production facility which specializes in cannabis extraction and processing. With the recent acquisition of Starseed Medicinal Inc., a medical-centric licensed holder with operations in Bowmanville, Ontario, WeedMD has expanded its multi-channeled distribution strategy. Starseed’s industry-first, exclusive partnerships with union groups, employers and benefit providers in Canada, complements WeedMD’s direct sales to medical patients. The Company maintains strategic relationships across the seniors’ market and supply agreements with Shoppers Drug Mart as well as six provincial distribution agencies where its adult-use brands Color Cannabis and Saturday are sold.


Follow WeedMD, Color Cannabis & Starseed: 


Facebook: https://www.facebook.com/weedmd/
LinkedIn: https://ca.linkedin.com/company/weedmd
Twitter: https://twitter.com/WeedMD
Instagram: https://www.instagram.com/weedmd/


Instagram: https://www.instagram.com/callitcolor/
&
Instagram: https://www.instagram.com/starseedca/


For further information, please contact:


For Investor Enquiries:
Stephen Ng
Chief Strategy Officer
Email: investor@weedmd.com


For Media Enquiries:
Marianella delaBarrera
VP, Communications & Corporate Affairs
Tel: 416-897-6644
Email: marianella@weedmd.com


Forward Looking Information


This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation which are based upon WeedMD's current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as "expect", "likely", "may", "will", "should", "intend", "anticipate", "potential", "proposed", "estimate" and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions "may", "would" or "will" happen, or by discussions of strategy.


The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Forward-looking information in this news release include, but are not limited to, statements with respect to internal expectations, expectations with respect to actual production volumes, expectations for future growing capacity and the completion of any capital project or expansions. Forward-looking information necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of WeedMD to implement its business strategies; competition; crop failure; and other risks.


Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, WeedMD does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for WeedMD to predict all such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in WeedMD's Annual Information Form dated June 21, 2019 (the "AIF") and other disclosure documents of WeedMD filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in the AIF and other disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.


NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE 



Primary Logo


!
Thumb 8020 monitor 200200 2

8020 Admin

10 days ago

8020 Admin posted a press release WeedMD Subsidiary Starseed Medicinal Signs the International Union of Painters and Allied Trades to Medical Cannabis Program in WEEDMD INC.

Starseed is now the preferred medical cannabis supplier to IUPAT Province of Ontario Health & Welfare Trust Fund through their benefits program


TORONTO, Feb. 24, 2020 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce that its subsidiary Starseed Medicinal Inc. (“Starseed”) is now the preferred supplier of medical cannabis to the IUPAT Province of Ontario Health & Welfare Trust Fund’s participants. The agreement provides approximately 7,000 IUPAT members and their dependents with medical cannabis as an insured benefit, with no co-pay or out-of-pocket costs.


“We are honoured to welcome the IUPAT members to Starseed’s full-service medical platform which is now being sourced from WeedMD’s medical-grade cannabis production platform,” said Angelo Tsebelis, CEO of WeedMD. “Our end-to-end service model eliminates the many barriers associated with traditional ways of accessing cannabis and is transforming how Canadians access medical cannabis. We are pleased to work with progressive partners to continue to legitimize cannabis as an effective treatment option.” 


“Providing our members with safe access to a broad and diverse range of medical cannabis therapies to suit their individual health and wellness needs is a positive step forward in sourcing alternatives to traditional pharma therapies,” said Jeffrey C. Baldwin, President – Benefit Plan Administrators (BPA) Limited, the administrator of the International Union of Painters and Allied Trades. “As cannabis industry leaders, Starseed and WeedMD are trusted sources of medical cannabis and we’re proud to partner with them to facilitate safe and affordable access for our members.”


Starseed and WeedMD are focused on delivering premium medical cannabis products through a unique education and service model. Access WeedMD’s investor presentation here.


Investor Relations Service Agreement


WeedMD also announced today that it has engaged KCSA Strategic Communications (“KCSA”), to provide investor relations services effective as of February 24, 2020 (the “Service Agreement”).  Pursuant to the Service Agreement, KCSA will provide comprehensive investor relations services for an initial term of six months and unless terminated by either party, will thereafter be automatically renewed on a month-to-month basis.  Pursuant to the Service Agreement, WeedMD will pay KCSA a monthly base fee of US$8,000, plus reasonable out-of-pocket expenses.  KCSA does not currently own any shares of WeedMD nor does it have any other direct or indirect interest in WeedMD. 


About WeedMD Inc.


WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer of cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, Ontario. WeedMD also operates CX Industries Inc., a wholly-owned subsidiary of WeedMD Inc., from the Company’s fully-licensed 26,000 sq. ft. Aylmer, Ontario production facility which specializes in cannabis extraction and processing. With the recent acquisition of Starseed Medicinal Inc., a medical-centric licensed holder with operations in Bowmanville, Ontario, WeedMD has expanded its multi-channeled distribution strategy. Starseed’s industry-first, exclusive partnerships with union groups, employers and benefit providers in Canada, complements WeedMD’s direct sales to medical patients. The Company maintains strategic relationships across the seniors’ market and supply agreements with Shoppers Drug Mart as well as six provincial distribution agencies where its adult-use brands Color Cannabis and Saturday are sold.


Follow WeedMD, Color Cannabis & Starseed: 


Facebook: https://www.facebook.com/weedmd/
LinkedIn: https://ca.linkedin.com/company/weedmd
Twitter: https://twitter.com/WeedMD
Instagram: https://www.instagram.com/weedmd/
Instagram: https://www.instagram.com/callitcolor/|
&
Instagram: https://www.instagram.com/starseedca/


For further information, please contact:


For Investor Enquiries:
Stephen Ng
Chief Strategy Officer
Email: investor@weedmd.com


For Media Enquiries:
Marianella delaBarrera
VP, Communications & Corporate Affairs
Tel: 416-897-6644
Email: marianella@weedmd.com


Forward Looking Information


This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation which are based upon WeedMD's current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as "expect", "likely", "may", "will", "should", "intend", "anticipate", "potential", "proposed", "estimate" and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions "may", "would" or "will" happen, or by discussions of strategy.


The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Forward-looking information in this news release include, but are not limited to, statements with respect to internal expectations, expectations with respect to actual production volumes, expectations for future growing capacity and the completion of any capital project or expansions. Forward-looking information necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of WeedMD to implement its business strategies; competition; crop failure; and other risks.


Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, WeedMD does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for WeedMD to predict all such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in WeedMD's Annual Information Form dated June 21, 2019 (the "AIF") and other disclosure documents of WeedMD filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in the AIF and other disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.


NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE


 Primary Logo


!
Thumb 8020 monitor 200200 2

8020 Admin

21 days ago

8020 Admin posted a press release WeedMD Subsidiary Starseed Medicinal Secures Cannabis Research Licence from Health Canada in WEEDMD INC.

New licence allows for ongoing product development and the evaluation of cannabis concentrates in portable vaporizer devices for optimal formulations


TORONTO, Feb. 13, 2020 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce that its subsidiary Starseed Medicinal Inc. (“Starseed”) has been awarded a cannabis research licence by Heath Canada (“Research Licence”). This allows for the testing of cannabis concentrates pertaining specifically to vaporization (vape) products in development testing at its Bowmanville, Ontario facility.


“With the evolution of next generation cannabis products such as extracts for vaporization, we want to ensure we drive important data collection forward on behalf of our patients and consumers,” said Angelo Tsebelis, CEO of WeedMD. “We are diligently assessing new cannabis products - in this case, specific to vapes - to determine optimum formulations that will result in the best performance and delivery of medical cannabis, as well as consumer acceptability.”


The Research Licence gives way to research activities and protocols that involve direct handling and storage of cannabis. It also allows for the administration and distribution of cannabis to focus group subjects for assessment of taste, sight, smell and/or touch. The research program is also expected to assess the effect of storage conditions on vaporization device cartridges to ensure product stability in various use conditions over time.


WeedMD also announced that as part of the transaction with Starseed Holdings Inc., the Company granted the following options: 5,674,875 options with an exercise price of $0.98 per share expiring November 3, 2022; and, 900,311 WeedMD options with an exercise price of $3.26 per share expiring November 1, 2023.


Access WeedMD’s investor presentation here.


About WeedMD Inc.


WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer of cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, Ontario. WeedMD also operates CX Industries Inc., a wholly-owned subsidiary of WeedMD Inc., from the Company’s fully-licensed 26,000 sq. ft. Aylmer, Ontario production facility which specializes in cannabis extraction and processing. With the recent acquisition of Starseed Medicinal Inc., a medical-centric licensed holder with operations in Bowmanville, Ontario, WeedMD has expanded its multi-channeled distribution strategy. Starseed’s industry-first, exclusive partnership with LiUNA, the largest construction union in Canada, along with other employers and union groups complements WeedMD’s direct sales to medical patients. The Company maintains strategic relationships across the seniors’ market and supply agreements with Shoppers Drug Mart as well as six provincial distribution agencies where its adult-use brands Color Cannabis and Saturday are sold.


Follow WeedMD, Color Cannabis & Starseed: 


Facebook: https://www.facebook.com/weedmd/
LinkedIn: https://ca.linkedin.com/company/weedmd
Twitter: https://twitter.com/WeedMD
Instagram: https://www.instagram.com/weedmd/


Instagram: https://www.instagram.com/callitcolor/
&
Instagram: https://www.instagram.com/starseedca/


For further information, please contact:


For Investor Enquiries:
Stephen Ng
Chief Strategy Officer
Email: investor@weedmd.com


For Media Enquiries:
Marianella delaBarrera
VP, Communications & Corporate Affairs
Tel: 416-897-6644
Email: marianella@weedmd.com


To learn more, visit us at www.weedmd.com


Forward Looking Information


This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation which are based upon WeedMD's current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as "expect", "likely", "may", "will", "should", "intend", "anticipate", "potential", "proposed", "estimate" and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions "may", "would" or "will" happen, or by discussions of strategy.


The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Forward-looking information in this news release include, but are not limited to, statements with respect to internal expectations, expectations with respect to actual production volumes, expectations for future growing capacity and the completion of any capital project or expansions. Forward-looking information necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of WeedMD to implement its business strategies; competition; crop failure; and other risks.


Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, WeedMD does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for WeedMD to predict all such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in WeedMD's Annual Information Form dated June 21, 2019 (the "AIF") and other disclosure documents of WeedMD filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in the AIF and other disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.


NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE


Primary Logo


!
Thumb 8020 monitor 200200 2

8020 Admin

24 days ago

8020 Admin posted a press release WeedMD Subsidiary Starseed Medicinal Signs Innovative Benefits Provider myHSA to Medical Cannabis Program in WEEDMD INC.

Starseed and WeedMD become preferred medical cannabis suppliers to over 51,000 myHSA clients across Canada


TORONTO, Feb. 10, 2020 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce that its subsidiary Starseed Medicinal Inc. (“Starseed”) is now the preferred supplier of medical cannabis to over 51,000 eligible myHSA participants across Canada. Selling its platform through a network of over 2,600 advisors, working with over 8,500 employers, myHSA is widely recognized for its unique digital wellness and reimbursement platform that provides a flexible, interactive benefits menu.


“More companies are recognizing that wellness programs are an effective way to engage employees in healthier living and we’re pleased to partner with innovative benefits provider myHSA as it looks to expand access to quality cannabis products to its 51,000 members,” said Angelo Tsebelis, CEO of WeedMD. “With the onset of flexible digital solutions, myHSA’s eligible participants get direct access to our patient portals and full-service medical cannabis program as well as easy digital access to claim reimbursement and adjudication.”

“At myHSA, we strongly believe that employees need to be in control of their wellness journey and with the advent of alternative therapies, we wanted to partner with a trusted source of medical cannabis products to ensure our participants have access to top quality products from Starseed and WeedMD,” said Tim Kane, CEO of myHSA. “We’ve created a platform that empowers participants to choose how they would like to spend their wellness dollars as a way to motivate and inspire a more holistic approach to benefits coverage.”


Launched in 2013, myHSA has grown and is the main spending account provider to over 51,000 employees across Canada. The myHSA system is a software that is used by advisors to implement different forms of health spending accounts, insurance products, and other unique employee benefits. More about myHSA here.


Access WeedMD’s investor presentation here.


About WeedMD Inc.


WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer of cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, Ontario. WeedMD also operates CX Industries Inc., a wholly-owned subsidiary of WeedMD Inc., from the Company’s fully-licensed 26,000 sq. ft. Aylmer, Ontario production facility which specializes in cannabis extraction and processing. With the recent acquisition of Starseed Medicinal Inc., a medical-centric licensed holder with operations in Bowmanville, Ontario, WeedMD has expanded its multi-channeled distribution strategy. Starseed’s industry-first, exclusive partnership with LiUNA, the largest construction union in Canada, along with other employers and union groups complements WeedMD’s direct sales to medical patients. The Company maintains strategic relationships across the seniors’ market and supply agreements with Shoppers Drug Mart as well as six provincial distribution agencies where its adult-use brands Color Cannabis and Saturday are sold.


Follow WeedMD, Color Cannabis & Starseed: 


Facebook: https://www.facebook.com/weedmd/
LinkedIn: https://ca.linkedin.com/company/weedmd
Twitter: https://twitter.com/WeedMD
Instagram: https://www.instagram.com/weedmd/


Instagram: https://www.instagram.com/callitcolor/
&
Instagram: https://www.instagram.com/starseedca/


For further information, please contact:


For Investor Enquiries:
Stephen Ng
Chief Strategy Officer
Email: investor@weedmd.com


For Media Enquiries:
Marianella delaBarrera
VP, Communications & Corporate Affairs
Tel: 416-897-6644
Email: marianella@weedmd.com


To learn more, visit us at www.weedmd.com


Forward Looking Information


This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation which are based upon WeedMD's current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as "expect", "likely", "may", "will", "should", "intend", "anticipate", "potential", "proposed", "estimate" and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions "may", "would" or "will" happen, or by discussions of strategy.


The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Forward-looking information in this news release include, but are not limited to, statements with respect to internal expectations, expectations with respect to actual production volumes, expectations for future growing capacity and the completion of any capital project or expansions. Forward-looking information necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of WeedMD to implement its business strategies; competition; crop failure; and other risks.


Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, WeedMD does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for WeedMD to predict all such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in WeedMD's Annual Information Form dated June 21, 2019 (the "AIF") and other disclosure documents of WeedMD filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in the AIF and other disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.


NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE


Primary Logo


!
Thumb 8020 monitor 200200 2

8020 Admin

29 days ago

8020 Admin posted a press release WeedMD Wins Award for London's Best Places to Work 2020 in WEEDMD INC.


TORONTO, Feb. 05, 2020 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce that it has been named winner in the large-size business category of London’s Best Places to Work 2020 awards program, presented by London Inc. Magazine.


“These awards recognize employers in the southwestern Ontario area that have gone above and beyond to create outstanding workplace environments,” said Gord Delamont, founder and editor of London Inc. Magazine. “In recognition of this achievement, we are pleased to showcase WeedMD in the Best Places to Work 2020 feature cover story and we congratulate them for promoting a positive and trusting workspace that motivates staff to produce quality products to drive success.”


“This award is truly meaningful for the WeedMD team because our own employees nominated and championed the vote. Our people strategy is built on a strong sense of community that fosters pride, passion and collaboration at every level,” said Josephine DesLauriers, SVP of People, WeedMD. “We are thrilled to be selected as one of London’s Best Places to Work. Our highly engaged employee base remains the backbone of our world-class cannabis cultivation platform that now spans three production sites and two corporate offices, including our newly-minted London office.”


The annual awards recognize top workplaces in the London, Ontario region based on a comprehensive workplace survey conducted by Ahria Consulting, a human resources management consulting firm. Winners are chosen through a survey evaluation of multiple employee engagement metrics, including employee commitment, effort, and interest. WeedMD is a winner in the large-size business category.


WeedMD is currently nominated as a finalist for the London Chamber of Commerce Business Achievement Awards – in the Best Agricultural Business Category. The winners will be announced on March 25, 2020 in London. Last year, WeedMD was named the top licensed producer in Indeed’s Hottest Places to Work according to Indeed job seekers.


Access WeedMD’s investor presentation here.


About WeedMD Inc.


WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer of cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, Ontario. WeedMD also operates CX Industries Inc., a wholly-owned subsidiary of WeedMD Inc., from the Company’s fully-licensed 26,000 sq. ft. Aylmer, Ontario production facility which specializes in cannabis extraction and processing. With the recent acquisition of Starseed Medicinal Inc., a medical-centric licensed holder with operations in Bowmanville, Ontario, WeedMD has expanded its multi-channeled distribution strategy. Starseed’s industry-first, exclusive partnership with LiUNA, the largest construction union in Canada, along with other employers and union groups complements WeedMD’s direct sales to medical patients. The Company maintains strategic relationships across the seniors’ market and supply agreements with Shoppers Drug Mart as well as six provincial distribution agencies where its adult-use brands Color Cannabis and Saturday are sold.


Follow WeedMD, Color Cannabis & Starseed: 


Facebook: https://www.facebook.com/weedmd/
LinkedIn: https://www.linkedin.com/company/weedmd/?originalSubdomain=fr
Twitter: https://twitter.com/WeedMD
Instagram: https://www.instagram.com/weedmd/
Instagram: https://www.instagram.com/callitcolor/
Instagram: https://www.instagram.com/starseedca/


For further information, please contact:


For Investor Enquiries:
Stephen Ng
Chief Strategy Officer
Email: investor@weedmd.com


For Media Enquiries:
Marianella delaBarrera
VP, Communications & Corporate Affairs
Tel: 416-897-6644
Email: marianella@weedmd.com


To learn more, visit us at www.weedmd.com

Forward Looking Information


This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation which are based upon WeedMD's current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as "expect", "likely", "may", "will", "should", "intend", "anticipate", "potential", "proposed", "estimate" and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions "may", "would" or "will" happen, or by discussions of strategy.


The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Forward-looking information in this news release include, but are not limited to, statements with respect to internal expectations, expectations with respect to actual production volumes, expectations for future growing capacity and the completion of any capital project or expansions. Forward-looking information necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of WeedMD to implement its business strategies; competition; crop failure; and other risks.


Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, WeedMD does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for WeedMD to predict all such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in WeedMD's Annual Information Form dated June 21, 2019 (the "AIF") and other disclosure documents of WeedMD filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in the AIF and other disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.


NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE 



Primary Logo


!
Thumb 8020 monitor 200200 2

8020 Admin

2 months ago

8020 Admin posted a press release WeedMD to Hold Special Meeting of Shareholders on February 4th, 2020 at 10:00 a.m. to Finalize $25M Strategic Equity Investment in WEEDMD INC.


TORONTO, Jan. 20, 2020 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to confirm that a special meeting (“Meeting”) of shareholders (the “Shareholders”) of WeedMD will take place as scheduled on February, 4, 2020 at 10:00 a.m. (EST) at Fogler, Rubinoff LLP, located at TD Centre North Tower, Suite 3000, 77 King Street West, Toronto, Ontario.


The Meeting is being held in connection with the private placement of subscription receipts (the “Subscription Receipts”) with the LiUNA Pension Fund of Central and Eastern Canada (“LPF”) for gross proceeds of $25 million, which was completed as part of WeedMD's acquisition of Starseed Holdings Inc. ("Starseed").  Upon WeedMD receiving the requisite shareholder approvals at the Meeting, the Subscription Receipts will automatically convert into WeedMD common shares. Further details about the financing are contained in the Meeting information circular (the "Circular") which is available for download on WeedMD’s SEDAR profile here.


Shareholders as of the record date of December 30, 2019 will have the right to vote by proxy or in person at the Meeting. All Shareholder votes are important and each is encouraged to take the time to read the Circular and vote prior to the voting deadline of January 31, at 10:00 a.m. (EST).


In connection with the closing of the Starseed acquisition, WeedMD will be issuing 538,756 common shares to Stoic Advisory Inc. as consideration for financial advisory services provided to WeedMD.  In addition, upon completion of the $25 million equity investment, an additional 153,637 common shares will be issued to Stoic.


Access WeedMD’s investor presentation here and AGM corporate video highlights here.


About WeedMD Inc.


WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer of cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, Ontario. WeedMD also operates CX Industries Inc., a wholly-owned subsidiary of WeedMD Inc., from the Company’s fully-licensed 26,000 sq. ft. Aylmer, Ontario production facility which specializes in cannabis extraction and processing. With the recent acquisition of Starseed Medicinal Inc., a medical-centric licensed holder with operations in Bowmanville, Ontario, WeedMD has expanded its multi-channeled distribution strategy. Starseed’s industry-first, exclusive partnership with LiUNA, the largest construction union in Canada, along with other employers and union groups complements WeedMD’s direct sales to medical patients. The Company maintains strategic relationships across the seniors’ market and supply agreements with Shoppers Drug Mart as well as six provincial distribution agencies where its adult-use brands Color Cannabis and Saturday are sold.


Follow WeedMD, Color Cannabis & Starseed:                                                                       


Facebook: https://www.facebook.com/weedmd/
LinkedIn: https://ca.linkedin.com/company/weedmd 
Twitter: https://twitter.com/WeedMD
Instagram: https://www.instagram.com/weedmd/


Instagram: https://www.instagram.com/callitcolor/


&


Instagram: https://www.instagram.com/starseedca/


For further information, please contact:


For Investor Enquiries:
Stephen Ng
Chief Strategy Officer
Email: investor@weedmd.com


For Media Enquiries:
Marianella delaBarrera
VP, Communications & Corporate Affairs
Tel: 416-897-6644
Email: marianella@weedmd.com


To learn more, visit us at www.weedmd.com


Forward Looking Information


This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation which are based upon WeedMD's current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as "expect", "likely", "may", "will", "should", "intend", "anticipate", "potential", "proposed", "estimate" and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions "may", "would" or "will" happen, or by discussions of strategy.


The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Forward-looking information in this news release include, but are not limited to, statements with respect to internal expectations, expectations with respect to actual production volumes, expectations for future growing capacity and the completion of any capital project or expansions. Forward-looking information necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of WeedMD to implement its business strategies; competition; crop failure; and other risks.


Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, WeedMD does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for WeedMD to predict all such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in WeedMD's Annual Information Form dated June 21, 2019 (the "AIF") and other disclosure documents of WeedMD filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in the AIF and other disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.


NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE


Primary Logo


!
Thumb 8020 monitor 200200 2

8020 Admin

2 months ago

8020 Admin posted a press release WeedMD Subsidiary Starseed Medicinal Signs LiUNA's London, Ontario Local to Medical Cannabis Program in WEEDMD INC.

Starseed is now the preferred medical cannabis supplier to five LiUNA Locals including London Local 1059’s 4,000 members through their health benefit plan


TORONTO, Jan. 16, 2020 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce that its newly-acquired subsidiary Starseed Medicinal Inc. (“Starseed”) has launched its full-service medical cannabis program as the preferred supplier of medical cannabis to  Labourers’ International Union of North America (LiUNA) Local 1059, headquartered in London, Ontario. The agreement provides approximately 4,000 members and their dependents with medical cannabis as a reimbursed benefit with no co-pay or out-of-pocket costs.


LiUNA is the largest construction union in Canada and LiUNA Local 1059 becomes the fifth LiUNA local to be onboarded onto Starseed’s medical cannabis program following launches in Toronto, Hamilton-Niagara and Windsor. Additional LiUNA locals are expected to join in 2020 along with other new insurance payor groups.


“Starseed’s full service medical platform – coupled with WeedMD’s medical-grade cannabis products - is revolutionizing the way Canadians access medical cannabis and we welcome LiUNA Local 1059 members to our program,” said Angelo Tsebelis, President of Starseed. “WeedMD and Starseed are improving fair and safe access to medical cannabis with an end-to-end service model that eliminates many of the practical and financial barriers associated with traditional ways of accessing cannabis as a medicine.” 


“It’s important to the Local 1059 Benefit Trustees that our 4,000 members have access to a broad and diverse range of medical therapies to suit their individual healthcare needs. Having the opportunity to collaborate with some of the most trusted names in medical cannabis was a key driver for entering into this agreement with Starseed,” said Brandon MacKinnon, Business Manager of LiUNA Local 1059. “Additionally, WeedMD has a strong reputation in our city and we’re looking forward to working with this local licensed producer to educate and facilitate medical cannabis access for our members.”


“We’ve kicked off the new year as a freshly integrated company and we’re thrilled at the many strategic business opportunities and partnerships that Starseed is bringing forward – perfectly aligned with our best-in-class cultivation program,” said Keith Merker, CEO of WeedMD. “As long-time supporters of our hometown London community coupled with our strong commitment to medical cannabis, we welcome LiUNA Local 1059 and look forward to the continued engagement with our local patient base.”


About WeedMD Inc.


WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer of cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, Ontario. WeedMD also operates CX Industries Inc., a wholly-owned subsidiary of WeedMD Inc., from the Company’s fully-licensed 26,000 sq. ft. Aylmer, Ontario production facility which specializes in cannabis extraction and processing. With the recent acquisition of Starseed Medicinal Inc., a medical-centric licensed holder with operations in Bowmanville, Ontario, WeedMD has expanded its multi-channeled distribution strategy. Starseed’s industry-first, exclusive partnership with LiUNA, the largest construction union in Canada, along with other employers and union groups complements WeedMD’s direct sales to medical patients. The Company maintains strategic relationships across the seniors’ market and supply agreements with Shoppers Drug Mart as well as six provincial distribution agencies where its adult-use brands Color Cannabis and Saturday are sold.


Follow WeedMD, Color Cannabis & Starseed: 


Facebook: https://www.facebook.com/weedmd/
LinkedIn: https://www.linkedin.com/company/weedmd/?originalSubdomain=fr
Twitter: https://twitter.com/WeedMD
Instagram: https://www.instagram.com/weedmd/


Instagram: https://www.instagram.com/callitcolor/


 


&


Instagram: https://www.instagram.com/starseedca/


For further information, please contact:


For WeedMD Investor Enquiries:
Stephen Ng
Chief Strategy Officer
Email: investor@weedmd.com


For WeedMD Media Enquiries:
Marianella delaBarrera
VP, Communications & Corporate Affairs
Tel: 416-897-6644
Email: marianella@weedmd.com


For LiUNA Media Enquiries:
Victoria Mancinelli
Director of Communications, Public Relations and Marketing
Tel: 1-289-681-1703
Email: vmancinelli@liunaopdc.org


To learn more, visit us at www.weedmd.com


Forward Looking Information


This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation which are based upon WeedMD's current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as "expect", "likely", "may", "will", "should", "intend", "anticipate", "potential", "proposed", "estimate" and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions "may", "would" or "will" happen, or by discussions of strategy.


The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Forward-looking information in this news release include, but are not limited to, statements with respect to internal expectations, expectations with respect to actual production volumes, expectations for future growing capacity and the completion of any capital project or expansions. Forward-looking information necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of WeedMD to implement its business strategies; competition; crop failure; and other risks.


Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, WeedMD does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for WeedMD to predict all such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in WeedMD's Annual Information Form dated June 21, 2019 (the "AIF") and other disclosure documents of WeedMD filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in the AIF and other disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.


NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE


Primary Logo


!
Thumb 8020 monitor 200200 2

8020 Admin

2 months ago

8020 Admin posted a press release WeedMD Closes Acquisition of Starseed Holdings Inc. and $25 Million Subscription Receipt Financing in WEEDMD INC.

Company enhances management team & board of directors, announces new chair


TORONTO, Dec. 23, 2019 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, and Starseed Holdings Inc. (“Starseed”), a medically-focused, federally-licensed cannabis company, are pleased to announce the closing of the previously announced acquisition of Starseed Holdings by WeedMD (the “Acquisition”).


Concurrent with the closing, WeedMD also completed the previously announced private placement of subscription receipts (the “Subscription Receipts”) with the LiUNA Pension Fund of Central and Eastern Canada (“LPF”), for aggregate gross proceeds of $25 million. The issue price of each Subscription Receipt is $1.0832, and each Subscription Receipt shall be automatically exchangeable into one WeedMD common share upon its shareholders approving certain matters associated with the financing at a meeting scheduled for February 4, 2020.


“We officially welcome the Starseed team to the WeedMD family which together will kick-off 2020 as a very compelling, vertically-integrated cannabis company that will execute across the entire value chain,” said Keith Merker, CEO of WeedMD. “Starseed’s unique medical distribution platform complements WeedMD’s high-quality cultivation and processing platform. This partnership, along with the $25 million strategic equity investment by LPF, positions WeedMD and its shareholders with a fortified balance sheet and one of the most captive medical cannabis businesses in the country as we enter the new year.”


Management Team


Following today’s closing, Starseed’s management team, which brings extensive medical, operating, and financial expertise, in addition to strong industry and client relationships, integrates into WeedMD’s senior leadership team as follows:



  • Keith Merker, CEO (maintains role)

  • Angelo Tsebelis, formerly President of Starseed, assumes the role of President of WeedMD

  • Nichola Thompson, CFO (maintains role)

  • Stephen Ng, formerly CFO of Starseed, is appointed to Chief Strategy Officer of WeedMD

  • Dr. Peter Blecher, formerly Chief Medical Officer of Starseed, assumes the role of Chief Medical Officer of WeedMD


Additional information about WeedMD’s current management team can be found here.


Board Directors


In addition to the Starseed leadership appointments, WeedMD’s board of directors is now comprised of four representatives from WeedMD and three representatives from Starseed.


WeedMD is pleased to announce that seasoned industry leader George Scorsis is appointed as Executive Chair of its board of directors. For the last six months, Mr. Scorsis has served as executive advisor to the WeedMD board and leadership team and is widely recognized in the cannabis and beverage industries for building, leading and managing high-performing management teams.


WeedMD extends its gratitude to Michael Kraft who has served as Chair of its board of directors since the Company’s inception. As one of WeedMD’s co-founders, Mr. Kraft has been integral to its growth and success over the years and we are pleased he has accepted the role of strategic advisor to the board which includes the existing WeedMD directors:



  • Keith Merker, currently CEO of WeedMD

  • Gail Paech, formerly Associate Deputy Minister, Ministry of Health, Ontario

  • Michael Pesner, previously on the board of SAQ (Société des alcools du Québec),  and KPMG executive leader


WeedMD is pleased to welcome three new board directors from Starseed:  



  • Angelo Tsebelis, currently President of WeedMD

  • G. Edmund King, former CEO and Chairman of CIBC Wood Gundy

  • Dr. Hugh Scully, previously President of both the Ontario & Canadian Medical Associations


Additional information about WeedMD’s current board of directors can be found here.


The Company would also like to thank Rick Moscone and Kevin McGovern who have elected to step down following three years and one year of service, respectively.


Pursuant to the Acquisition, WeedMD acquired 100% of the issued and outstanding common shares of Starseed and in exchange Starseed shareholders received a total of approximately 71.8 million common shares of WeedMD. Certain shareholders of Starseed, holding approximately 49 million common shares of WeedMD, have agreed to an 18-month lock-up and leak out agreement.


About WeedMD Inc.


WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer of cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, Ontario. WeedMD also operates CX Industries Inc., a wholly-owned subsidiary of WeedMD Inc., from the Company’s fully-licensed 26,000 sq. ft. Aylmer, Ontario production facility which specializes in cannabis extraction and processing. With the recent acquisition of Starseed Medicinal Inc., a medical-centric licensed holder with operations in Bowmanville, Ontario, WeedMD has expanded its multi-channeled distribution strategy. Starseed’s industry-first, exclusive partnership with LiUNA, the largest construction union in Canada, along with other employers and union groups complements WeedMD’s direct sales to medical patients. The Company maintains strategic relationships across the seniors’ market and supply agreements with Shoppers Drug Mart as well as six provincial distribution agencies where its adult-use brands Color Cannabis and Saturday are sold.


Follow WeedMD, Color Cannabis & Starseed: 


Facebook
LinkedIn
Twitter
Instagram Weed MD
Instagram Color Cannabis
Instagram Starseed


For further information, please contact:


For Investor Inquiries:
James Williams
Director, Capital Markets
Email: investor@weedmd.com


For Media Enquiries:
Marianella delaBarrera
VP, Communications & Corporate Affairs
Tel: 416-897-6644
Email: marianella@weedmd.com


To learn more, visit us at www.weedmd.com


Forward Looking Information:


This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation which are based upon WeedMD’s current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as “expect”, “likely”, “may”, “will”, “should”, “intend”, “anticipate”, “potential”, “proposed”, “estimate” and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions “may”, “would” or “will” happen, or by discussions of strategy.


The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Forward-looking information in this news release include, but are not limited to, statements with respect to internal expectations, expectations with respect to actual production volumes, expectations for future growing capacity and the completion of any capital project or expansions. Forward-looking information necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of WeedMD to implement its business strategies; competition; crop failure; and other risks.


Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, WeedMD does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for WeedMD to predict all such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in WeedMD’s Annual Information Form dated June 21, 2019 (the “AIF”) and other disclosure documents of WeedMD filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in the AIF and other disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.


NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE


Primary Logo


!
Thumb 8020 monitor 200200 2

8020 Admin

3 months ago

8020 Admin posted a press release WeedMD Posts Open Letter to Shareholders in WEEDMD INC.


TORONTO, Dec. 02, 2019 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, announced today that it has posted an open letter to its shareholders to provide additional background information about its recent 27-acre outdoor harvest yields, the Starseed Holdings Inc. (“Starseed”) acquisition, and the $25 million strategic investment from the Labourers’ Pension Fund of Central and Eastern Canada (known as “LPF”) (the “Transaction”). The Shareholder Letter was cascaded earlier today and can be found on WeedMD’s website here.


Access the WeedMD and Starseed Transaction deck here.


About WeedMD Inc.


WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer of cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, Ontario. WeedMD also operates CX Industries Inc., a wholly-owned subsidiary of WeedMD Inc. CX Industries operates out of the Company’s fully-licensed 26,000 sq. ft. Aylmer, Ontario production facility which specializes in cannabis extraction and processing. WeedMD has a multi-channeled distribution strategy that includes selling directly to medical patients, strategic relationships across the seniors’ market and supply agreements with Shoppers Drug Mart as well as six provincial distribution agencies where WeedMD’s adult-use brand Color Cannabis is sold.

Follow WeedMD & Color Cannabis: 


Facebook: https://www.facebook.com/weedmd/
LinkedIn: https://www.linkedin.com/company/weedmd/?originalSubdomain=fr
Twitter: https://twitter.com/WeedMD
Instagram: https://www.instagram.com/weedmd/
&
https://www.instagram.com/callitcolor/   


For further information, please contact WeedMD Inc.:


For Investor Inquiries:
James Williams
Director, Capital Markets
Email: investor@weedmd.com


For Media Inquiries:


Marianella delaBarrera
VP, Communications & Corporate Affairs
Tel: 416-897-6644
Email: marianella@weedmd.com
To learn more, visit us at www.weedmd.com


Forward Looking Information


This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation which are based upon WeedMD's current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as "expect", "likely", "may", "will", "should", "intend", "anticipate", "potential", "proposed", "estimate" and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions "may", "would" or "will" happen, or by discussions of strategy.


The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Forward-looking information in this news release include, but are not limited to, statements with respect to internal expectations, expectations with respect to actual production volumes, expectations for future growing capacity and the completion of any capital project or expansions. Forward-looking information necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of WeedMD to implement its business strategies; competition; crop failure; and other risks.


Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, WeedMD does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for WeedMD to predict all such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in WeedMD's Annual Information Form dated June 21, 2019 (the "AIF") and other disclosure documents of WeedMD filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in the AIF and other disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.


NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE


Primary Logo


!